In metastatic cancer, these pathways are activated by pro-inflammatory cytokines such as interleukin 6 (IL-6), interleukin 1 (IL-1), tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) [17–20]. The gene discussed is IFNG; the disease is metastatic malignant neoplasm.